BlackRock’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $359M | Sell |
|
|||||
|
2025
Q2 | $346M | Buy |
|
|||||
|
2025
Q1 | $399M | Sell |
|
|||||
|
2024
Q4 | $909M | Buy |
|
|||||
|
2024
Q3 | $1.22B | Buy |
|
|||||
|
2024
Q2 | $751M | Buy |
|
|||||
|
2024
Q1 | $650M | Buy |
|
|||||
|
2023
Q4 | $539M | Buy |
|
|||||
|
2023
Q3 | $378M | Buy |
|
|||||
|
2023
Q2 | $353M | Buy |
|
|||||
|
2023
Q1 | $190M | Sell |
|
|||||
|
2022
Q4 | $245M | Buy |
|
|||||
|
2022
Q3 | $83.8M | Buy |
|
|||||
|
2022
Q2 | $71.2M | Buy |
|
|||||
|
2022
Q1 | $69.7M | Buy |
|
|||||
|
2021
Q4 | $66.1M | Buy |
|
|||||
|
2021
Q3 | $64.1M | Buy |
|
|||||
|
2021
Q2 | $52.8M | Buy |
|
|||||
|
2021
Q1 | $43.2M | Buy |
|
|||||
|
2020
Q4 | $45M | Buy |
|
|||||
|
2020
Q3 | $49.6M | Buy |
|
|||||
|
2020
Q2 | $2.52M | Buy |
|